Insider screener

Period: 12 months Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

22,785 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

22,785 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

22,785 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

22,785 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
22,785 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
22,785 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

22,785 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
16 Mar 2026
Mark A. Morais Chief Operating Officer
Sold at will
$16.63K 1,804 at 9.22
2.5%
Not planned
16 Mar 2026
Christopher C. Swenson Chief Legal Officer
Sold at will
$16.53K 18,366 at 0.90
0.9%
Not planned
16 Mar 2026
Arjun Agarwal Senior Vice President, Finance
Sold at will
$16.31K 395 at 41.30
2.1%
Not planned
16 Mar 2026
Edward J Zecchini See Remarks
Sold at will
$16.11K 2,014 at 8.00
1.8%
Not planned
16 Mar 2026
Haitao Cui Executive Vice President
Sold at will
$15.71K 3,888 at 4.04
2.8%
Not planned
16 Mar 2026
Jason C Jones Chief Operating Officer · indirect
Bought
$15.50K 1,308 at 11.85
41.6%
First buy on file
16 Mar 2026
Rabourn Amy Zaremba Head of Fin. Quality Assurance
Sold at will
$14.77K 2,816 at 5.25
1.5%
Not planned
16 Mar 2026
Husnal Shah Chief Product Officer
Sold at will
$13.60K 3,651 at 3.73
17.9%
Not planned
16 Mar 2026
Mary Celeste Fruge VP, General Counsel
Sold on a plan
$13.56K 1,000 at 13.56
0.4%
Planned (10b5-1)
16 Mar 2026
Sarah A. Mussetter Chief Legal Officer
Sold at will
$12.96K 4,037 at 3.21
3.5%
Not planned
16 Mar 2026
Benjamin Machinas Beneski SVP, Chief Technical Officer
Sold at will
$11.94K 4,835 at 2.47
2.4%
Not planned
16 Mar 2026
Aaron Deykin Chief Medical Officer
Sold at will
$8.31K 894 at 9.29
2.7%
Not planned
16 Mar 2026
Alina Kerdman SVP, Controller & CAO
Sold on a plan
$7.96K 131 at 60.78
17.3%
Planned (10b5-1)
16 Mar 2026
Robert E. Harris Chief Accounting Officer
Sold at will
$7.58K 665 at 11.40
7.4%
Not planned
16 Mar 2026
Michael Wayne Domino Jr. President, DTR Division
Sold on a plan
$7.46K 2,083 at 3.58
0.1%
Planned (10b5-1)
16 Mar 2026
Kevin Drohan VP & Chief Accounting Officer
Sold on a plan
$7.46K 85 at 87.73
1.1%
Planned (10b5-1)
16 Mar 2026
Nathan B. Theurer VP - Global Controller and CAO
Sold on a plan
$7.03K 35 at 200.80
26.7%
Planned (10b5-1)
16 Mar 2026
Adam Houghton Chief Business Officer
Sold at will
$6.49K 699 at 9.29
2.8%
Not planned
16 Mar 2026
Steven P. Coen See remarks
Sold at will
$4.77K 708 at 6.74
7.2%
Not planned
16 Mar 2026
Jesse Griffith Chief Operations Officer
Sold at will
$4.50K 1,402 at 3.21
3.2%
Not planned
16 Mar 2026
Allison Ambrose General Counsel
Sold at will
$4.41K 475 at 9.29
2.8%
Not planned
16 Mar 2026
Jennifer Stevens Chief Regulatory Officer
Sold at will
$3.19K 774 at 4.12
0.6%
Not planned
16 Mar 2026
Bryan F. Cox Chief of Research
Sold at will
$2.39K 579 at 4.12
0.4%
Not planned
16 Mar 2026
Murray Stahl President/Co-Portfolio Manager · indirect
Bought 6×
$2.36K 774 at 3.05
0.2%
16 Mar 2026
Claiborne Benson Smith Gen Counsel, Corp Secretary
Bought
$1.92K 1,000 at 1.92
1.0%
16 Mar 2026
Richard Marshak Chief Commercial Officer
Sold at will
$1.73K 419 at 4.12
0.4%
Not planned
16 Mar 2026
Jodi Devlin Chief of Clinical Operations
Sold at will
$1.12K 273 at 4.12
0.3%
Not planned
16 Mar 2026
Murray Stahl President/Co-Portfolio Manager
Bought
$1.10K 360 at 3.05
0.2%
16 Mar 2026
Claudia Hughes SVP & Chief Sales Officer
Bought
$457.95 15 at 30.53
0.0%
Largest buy in 3 yrs
16 Mar 2026
Melanie F Goins General Counsel and CPO
Sold on a plan
$379.50 69 at 5.50
0.0%
Planned (10b5-1)
16 Mar 2026
Joseph Miller VP & Controller
Bought
$109.31 1 at 115.55
0.0%
13 Mar 2026
Matthew Rabinowitz Executive Chairman
Sold on a plan 5×
$14.18M 75,000 at 189.01
3.1%
Planned (10b5-1)
13 Mar 2026
Caroline Cochran Co-Founder, COO · indirect
Sold at will
$4.38M 72,960 at 60.00
8.8%
Not planned
13 Mar 2026
Andrew D Lundquist Senior Vice President
Sold at will
$4.13M 34,500 at 119.68
66.4%
Sold half or more
13 Mar 2026
Matt Zmigrosky EVP, Chief Legal and Admin Off
Sold at will
$3.76M 20,899 at 180.00
25.7%
Not planned
13 Mar 2026
Scott Lish Chief Operating Officer
Sold at will
$3.20M 260,535 at 12.30
24.2%
Not planned
13 Mar 2026
Caroline Cochran Co-Founder, COO
Sold at will
$2.69M 44,828 at 60.00
5.9%
Not planned
13 Mar 2026
Christopher M Cuddy Senior Vice President
Sold at will
$2.57M 35,000 at 73.50
9.6%
Not planned
13 Mar 2026
Ian R Pinner Senior Vice President
Sold at will
$2.44M 34,106 at 71.53
27.3%
Not planned
13 Mar 2026
Heath Tarbert President
Sold on a plan 6×
$1.74M 15,000 at 116.04
2.5%
Planned (10b5-1)
13 Mar 2026
Dmitriy Dorosh Principal Accounting Officer
Sold at will 2×
$1.41M 3,109 at 453.42
2.7%
Not planned
13 Mar 2026
Rajeev Saggar Chief Medical Officer
Sold at will
$1.28M 35,365 at 36.30
16.9%
Not planned
13 Mar 2026
Joshua Jergensen President & COO
Sold at will
$1.25M 36,335 at 34.28
1.3%
Not planned
13 Mar 2026
Carmen Bozic EVP and CMO
Sold on a plan
$1.12M 2,329 at 481.79
6.2%
Planned (10b5-1)
13 Mar 2026
Hernan E. Mujica Chief Technology Officer
Sold at will
$850.00K 5,000 at 170.00
24.3%
Not planned
13 Mar 2026
Albert Barkmann Exec. VP and Chief Engineer
Sold at will
$731.60K 4,000 at 182.90
12.7%
Not planned
13 Mar 2026
Meghan Nicole Eilers EVP, M&M & GC
Sold at will
$634.46K 11,582 at 54.78
17.6%
Not planned
13 Mar 2026
Sarah Krepp Chief Human Resource Officer
Sold at will
$617.92K 16,261 at 38.00
9.9%
Not planned
13 Mar 2026
Lizette Benedi Herraiz General Counsel
Sold on a plan 2×
$607.59K 7,598 at 79.97
11.5%
Planned (10b5-1)
13 Mar 2026
Denise Clark McWatters EVP, Gen Counsel & Corp Sec
Sold at will
$495.46K 11,988 at 41.33
13.9%
Not planned
Showing 13,751–13,800 of 22,785. ← Newer Page 276 of 456 Older →